This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected.
The study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study.
The cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.
Age ≥ 18 years;
Emergency admission to a participating center, with spontaneous intracerebral hemorrhage confirmed by the first brain imaging (CT or MRI) performed at the time of initial treatment;
Obtaining non-opposition
First brain imaging performed outside a center participating in the study (e.g., peripheral center not recruiting);
vascular malformation (aneurysm, arteriovenous malformation, cavernoma, etc.);
intracranial tumor;
hemorrhagic transformation of a cerebral infarction;